Search
for
Sort by
Research 481–510 of 777
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- The Good and Bad News About New Drugs for Treating Alopecia Areata
- Mesenchymal-epidermal interactions in hair follicle cycling and regeneration
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Real-world evidence in alopecia areata treatment: A narrative review
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study
- Comparative characteristics of the effectiveness of drugs for the treatment of alopecia areata in childhood
- Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Effective treatment of alopecia universalis with oral tofacitinib: A case report
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Hidradenitis Suppurativa Tunnels: Unveiling a Unique Disease Entity
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Three Types of Alopecia in One Patient: A Case of Central Centrifugal Cicatricial Alopecia, Alopecia Areata, and Telogen Effluvium
- Update From Dermatology Nurses’ Association Convention 2025
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- The JAK/STAT signaling pathway: from bench to clinic
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Understanding autoimmunity of vitiligo and alopecia areata